Date of Document: March 1, 2024
CURRICULUM VITAE

Francisco A. Durazo MD
Professor
Department of Medicine
Division of Gastroenterology

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Prior
Peer Review
Title:
A Multi-Center Longitudinal Study of Drug and CAM- Induced Liver Injury
Source:
National Institutes of Health/Drug Induced Liver Injury Network (DILIN), University of California, Los Angeles
Role:
Principal Investigator, UCLA
PI:
Francisco A. Durazo, MD, FACP
Dates:
2008 - 2015
Direct Funds:
$181,275
  
Title:
Development of a National Hepatitis B Database and serum/tissue repository and long-term treatment trial
Source:
National Institutes of Health/HBV Research Network Database Protocol and Clinical Trial Study Proposals, University of California, Los Angeles
Role:
Co-Investigator
PI:
Steven Han, MD
Dates:
2008 - 2015
Direct Funds:
$1,163,500
  
Title:
Tobira Therapeutics Centaur Nonalcoholic Steatohepatitis (NASH) Study
Source:
Tobira Therapeutics
Role:
Principal Investigator, UCLA
Dates:
2015 - 2017
Direct Funds:
$900,000
  
Title:
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis.
Source:
Intercept Pharmaceuticals Inc. (747-303)
Role:
Principal Investigator
PI:
Francisco A. Durazo, MD, FACP
Dates:
2016 - 2018
Direct Funds:
$111,447
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Diagnosis and Treatment of Cholangiocarcinoma, University of Southern California Annual Liver Symposium, Los Angeles, California, 11/2000
Fulminant Liver Failure, Grand Rounds, Western Medical Center Santa Ana, California, 03/2001
Liver Transplantation, Post-AASLD Review Course Southern California Society for Gastroenterology, Laguna Beach, California, 12/2002
Management of Recurrent Hepatitis C, UCLA GI/Liver Fellows Annual Meeting, Mammoth, California, 05/2003
HCV-HIV Coinfection, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 11/2003
Recurrent Hepatitis C, UCLA Hepatology Symposium, Marina del Ray, California, 12/2003
Speaker and Moderator: Update in Gastroenterology and Hepatology: Case Vignettes and Panel Discussion, UCLA Division of Digestive and Liver Diseases, Los Angeles, California, 02/2004
Hepatitis A, B, and C, Grand Rounds, St. John's Regional Medical Center, Ventura, California, 04/2004
Hepatotoxicity, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 11/2004
Non-alcoholic Fatty Liver Disease, Update 2005: Gastroenterology and Hepatology for the Primary Care Physician UCLA Division of Digestive and Liver Diseases, Los Angeles, California, 02/2005
Hepatocellular Carcinoma, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 11/2005
Approach to the Patient with a Liver Mass, Update 2006: Gastrointestinal Oncology UCLA Division of Digestive and Liver Diseases, Los Angeles, California, 02/2006
Current and Future Treatments for Hepatitis C, State-of=the-Art Treatment for Diseases of the Liver UCLA Liver Disease Symposium, Los Angeles, California, 10/19/2006
Fulminant Liver Failure, Grand Rounds, Harbor-UCLA Medical Center, Los Angeles, California, 04/24/2007
Abnormal Liver Function Tests, Grand Rounds, Northridge Hospital, Northridge, California, 09/07/2007
Chair, Session 1: Epidemiology, Pathogenesis and Diagnosis of HCC, Hepatocellular Carcinoma: Multi-Disciplinary Management David Geffen School of Medicine at UCLA, Los Angeles, California, 11/10/2007
Biliary Case-Discussions, Post-AASLD Review Course Southern Society of Gastroenterology, Laguna Beach, California, 12/01/2007 - 12/02/2007
Clinical Update in the Management of Viral Hepatitis, Los Angeles Society of Pathologists Annual Seminar, City of Hope Duarte, California, 01/19/2008
Clinical Update in the Management of Viral Hepatitis, Los Angeles Society of Pathologists Annual Seminar, Duarte, California, 01/19/2008
Clinical Approach to Fatty Liver, UCLA Family Practice Refresher Course, Century City, California, 05/20/2008
Management of Hepatitis B and Hepatitis C, UCLA Family Practice Refresher Course, Century City, California, 05/20/2008
Approach to the patient with a Liver Lesion, Second Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/15/2008
Chair, Second Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/15/2008
Hepatocellular Carcinoma, Post-AASLD Review Course Southern Society of Gastroenterology, Laguna Beach, California, 11/22/2008
Overview of Hepatitis B, Hepatitis C, Hepatocellular Carcinoma and Treatment Modalities, Nursing Seminar on Transplantation Dumont-UCLA Liver Transplant Program, Los Angeles, California, 12/04/2008
Fulminant Liver Failure, Grand Rounds, UCLA Department of Internal Medicine, Los Angeles, California, 05/20/2009
Nonalcoholic Fatty Liver Disease, Internal Medicine Grand Rounds Kaiser Permanente, Los Angeles, California, 06/03/2009
Nonalcoholic Fatty Liver Disease, Medical Grand Rounds, Northridge Hospital, Northridge, California, 09/14/2009
Management of Pancreatic and Biliary Tumors, Interventional Radiology Forum, Santa Barbara, California, 11/06/2009
Surgical Resection vs. Liver Transplant for Primary and Secondary Liver Tumors, Interventional Radiology Forum, Santa Barbara, California, 11/06/2009
Management of Complications of Portal Hypertension, 3rd Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/14/2009
Chair, 3rd Annual UCLA Livre Diseases Symposium, Pasadena, California, 11/14/2009
Screening for Hepatocellular Carcinoma: Who and When?, Post-AASLD Review Course Southern California Society of Gastroenterology, Dana Point, California, 11/21/2009
Acute Liver Failure, Grand Rounds, Department of Internal Medicine, David Geffen School of Medicine at UCLA, 12/09/2009
Chair, 4th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/13/2010
Hepatic Encephalopathy, 4th UCLA Liver Diseases Symposium, Pasadena, California, 11/13/2010
Diagnosis and Management of Hepatorenal Syndrome, Post-AASLD Review Course Southern California Society of Gastroenterology, Dana Point, California, 11/20/2010
Update in Hepatic Encephalopathy, 5th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/12/2011
Chair, 5th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/12/2011
NASH Update: When to biopsy and what to do with the results? Panel Cases: HE Management, Gastric Varices, HCC: When is Sorafenib appropriate?, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Niguel, California, 11/19/2011
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, VA Los Angeles Ambulatory Care Center, Los Angeles, California, 05/08/2012
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, VA Santa Maria Clinic, Santa Maria, California, 07/25/2012
Chair, 6th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/03/2012
Hepatic Encephalopathy, 6th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/03/2012
Case Discussions: HCC, Fatty Liver and Alcoholic Liver Disease, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Liguel, California, 12/02/2012
Liver Lesions - What to Do, UCLA-Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/09/2013
A Practical Approach to the Fatty Liver, 40th Annual UCLA Family Medicine Refresher Course, Los Angeles, California, 05/21/2013
Chair, 7th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/19/2013
Drug and Herb-Induced Liver Injury (DILI and HILI): An Update, 7th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/19/2013
State of the Art Lecture: Therapies for Fatty Liver, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Niguel, California, 12/07/2013
Treatment of Hepatic Neoplasia, 2nd Annual UCLA-Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/09/2014
Chair, 8th Annual UCLA Liver Diseases Symposium: 30th Anniversary of Liver Transplantation at UCLA, Los Angeles, California, 11/01/2014
What's new in NASH, 8th Annual UCLA Liver Diseases Symposium: 30th Anniversary of Liver Transplantation at UCLA, Los Angeles, California, 11/01/2014
State of the Art Lecture: Non Alcoholic Fatty Liver Disease, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Niguel, California, 12/13/2014
Non Alcoholic Fatty Liver Disease, Grand Rounds, Providence Tarzana Hospital, Tarzana, California, 01/16/2015
Overview of Hepatitis C Etiology and Epidemiology in Hispanic Community, Hepatitis C Meeting, USC, Los Angeles, California, 08/11/2015
Dietary Supplements Induced Liver Injury, 9th Annual Liver Diseases Symposium, Pasadena, California, 11/07/2015
Chair, 9th Annual UCLA Liver Diseases Symposium, Pasadena, California, 11/07/2015
State of the Art Lecture: Strategies for the Management of Refractory Hepatic Encephalopathy, Post-AASLD Review Course Southern California Society Gastroenterology, Laguna Beach, California, 12/05/2015
Endoscopic Evaluation and Management of PSC, 4th Annual UCLA Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/11/2016
Current Clinical Concepts in Fatty Liver, 43rd Annual UCLA Family Medicine Refresher Course, Marina Del Ray, California, 05/24/2016
Chair, 10th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/29/2016
Session Chair - NAFLD: Medical and Surgical Therapies, 10th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/29/2016
Clinical Case Discussions, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 12/02/2016
A Practical Approach to Fatty Liver, 44th Annual UCLA Family Medicine Refresher Course, Marina Del Rey, California, 03/06/2017
The Epidemic of Fatty Liver, 5th Annual UCLA-Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/10/2017
Fatty Liver, UCLA GI Fellowship Clinical Case Conference, Los Angeles, California, 04/05/2017
Drug/Herbal Induced Liver Injury, UCLA GI Fellowship Conference, Los Angeles, California, 06/19/2017
Drug/Herbal Induced Liver Injury, Grand Rounds, Providence Holy Cross Medical Center, Mission Hills, California, 06/23/2017
Chair, 11th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/14/2017
Sclerosing Cholangitis: Emerging Etiologies, 11th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/14/2017
Drug-Induced Liver Injury, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach California, 12/08/2017
Panelist, Challenging Patient Cases, 6th Annual UCLA-Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/09/2018
Cholangiocarcinoma & Fibrolamellar Carcinoma, 1st Annual HALT HCC Multi Specialty Conference, Pasadena, California, 04/14/2018
Intestinal Microbiome and Liver Diseases, 12th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/20/2018
Chair, 12th Annual UCLA Liver Diseases Symposium, Pasadena, California, 10/20/2018
Clinical Case Discussions, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 12/08/2018
Panelist, Challenging Patient Cases, 7th Annual UCLA-Mellinkoff Gastroenterology Symposium, Beverly Hills, California, 03/02/2019
Course Chair, UCLA Solid Organ Transplant Symposium 2019, Los Angeles California, 06/14/2019
Liver: Acute Liver Failure, UCLA Solid Organ Transplant Symposium 2019, Los Angeles, California, 06/14/2019
Panelist: Clinical Case Discussions, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 12/07/2019
Acute Liver Failure, Department of Surgery Grand Rounds Medical College of Wisconsin, Virtual Conference, 08/26/2020
Acute Liver Failure, UCLA Department of Surgery Liver Transplant Program, Virtual Conference, 10/06/2020
Update in Liver Transplantation, Post-AASLD Review Course Southern California Society of Gastroenterology, Laguna Beach, California, 12/18/2022
Acute Liver Failure, Department of Medicine Grand Rounds Medical College of Wisconsin, Virtual Conference, 10/06/2023
Hepatic Malignancies, Annual AASLD Meeting Review Medical College of Wisconsin, Milwaukee Wisconsin, 02/10/2024
 
Regional
Clinical Vignettes, American College of Physicians Regional Meeting, Region II, Newport Beach, California, 01/1990
Fulminant Liver Failure, Gastrointestinal and Liver Diseases Conference at Yale University, New Haven, Connecticut, 05/31/2006
Treatment of Recurrent Hepatitis C, Grand Rounds, Nazih Zuhdi Transplant Institute, Oklahoma City, Oklahoma, 06/01/2010
Targeted Treatment for Hepatocellular Carcinoma to Optimize Outcomes in the Veteran Affairs Population, Grand Rounds, Kansas City VA Medical Center, Kansas City, Missouri, 08/17/2011
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, 08/20/2012
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, Louis A. Johnson VA Medical Center, Clarksburg, West Virginia, 09/12/2012
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, VA Eastern Colorado Health Care System, La Junta, Colorado, 09/28/2012
Navigating Hepatocellular Carcinoma: Applying Clinical Trials Data to Patient Care, Grand Rounds, VA Puget Sound Health Care System, Seattle, Washington, 10/03/2012
OLT: Improving Long-term Outcomes, Annual Meeting of the American Association for the Study of Liver Diseases: Meet the Professor Presentation, Washington, DC, 11/02/2013
Meeting the Challenge of the Fatty Liver, UCLA Primary Care Update, Las Vegas, Nevada, 04/18/2015
Acute Liver Failure, Grand Rounds, Medical College of Wisconsin, Milwaukee, Wisconsin, 10/08/2018
 
National
Recent Advances in Viral Hepatitis, Annual Meeting of the Mexican Society for Clinical Pathology, Mexico City, Mexico, 12/1996
Update in Viral Hepatitis, Annual Meeting of the Mexican Society for Clinical Pathology, Mexico City, Mexico, 09/1997
Complications of Endoscopic Therapy of The Upper GI Tract, National Meeting of the Mexican Society for Gastrointestinal Endoscopy: ERCP Live Demonstrations, Mexico City, Mexico, 09/1998
Management of Patients with Adenomatous Polyps and After Resection of Colon Cancer, National Meeting of the Mexican Society for Gastrointestinal Endoscopy: ERCP Live Demonstrations, Mexico City Mexico, 09/1998
Endoscopic Treatment of Diseases of the Pancreas, National Meeting of Mexican Society of Surgery: ERCP Live Demonstrations, Saltillo, Mexico, 03/1999
Treatment of Choledocolithiasis, National Meeting of Mexican Society of Surgery: ERCP Live Demonstrations, Saltillo, Mexico, 03/1999
Evaluation and Management of the Pre-Transplant Patient with Hepatitis C, International Symposium on Hepatitis C, Mexico City, Mexico, 03/2000
Fulminant Liver Failure and Artificial Liver Devices, American British Cowdray Hospital Annual Meeting, Mexico City, Mexico, 03/2000
Variceal Bleed: TIPSS vs. Endoscopic Band Ligation, National Meeting of the Mexican Association for Gastrointestinal Endoscopy, Ixtapa, Mexico, 09/2000
Video Presentation: Treatment of Esophageal Varices, National Meeting of the Mexican Association for Gastrointestinal Endoscopy, Ixtapa, Mexico, 09/2000
The Endoscopist and Liver Transplant, National Meeting of the Mexican Association for Gastrointestinal Endoscopy, Ixtapa, Mexico, 09/2000
Recurrent Hepatitis C, Hepatitis C Symposium, Mexico City, Mexico, 06/2003
State of the Art Lecture: Biliary Complications After Liver Transplantation, Mexican Association for Gastrointestinal Endoscopy, Mexico City, Mexico, 01/2004
New Trends, New Solutions, 28th Annual Seminar for GI Nurses and Associates, Los Angeles, California, 03/2004
Portal Hypertensive Gastropathy, Mexican Society for Gastrointestinal Endoscopy National Meeting: ERCP Live Demonstrations, Monterrey, Mexico, 09/2004
Tissue Sampling in Biliary Strictures, Mexican Society for Gastrointestinal Endoscopy National Meeting: ERCP Live Demonstrations, Monterrey, Mexico, 09/2004
State of the Art Lecture: Biliary Complications after Liver Transplantation, Mexican Society for Gastrointestinal Endoscopy National Meeting: ERCP Live Demonstrations, Acapulco, Mexico, 09/2005
Screening for Esophageal Varices, Mexican Society for Gastrointestinal Endoscopy National Meeting: ERCP Live Demonstrations, Acapulco, Mexico, 09/2005
Diagnostic Testing, Histology, Cirrhosis and Liver Biopsy, Hepatitis B and Infectious Disease 2006 National Training Program, Los Angeles, California, 04/2006
Recent Advances with Nucleoside/Nucleotide Analogues and Pegylated Interferons for HBV, Hepatitis B and Infectious Disease 2006 National Training Program, Los Angeles, California, 04/2006
Treatment of Difficult Populations, Hepatitis B and Infectious Disease 2006 National Training Program, Los Angeles, California, 04/2006
Acute Liver Failure, International Congress of Gastroenterology and Hepatology, Lima, Peru, 10/07/2009 - 10/10/2009
Downstaging of Hepatocellular Carcinoma, International Congress of Gastroenterology and Hepatology, Lima, Peru, 10/07/2009 - 10/10/2009
Hepatitis B: Strategies to Prevent Recurrence after Liver Transplantation, International Congress of Gastroenterology and Hepatology, Lima, Peru, 10/07/2009 - 10/10/2009
Treatment of Recurrent Hepatitis C, International Congress of Gastroenterology and Hepatology, Lima, Peru, 10/07/2009
Mass Lesions of the Liver, Audio-Digest CME/CE Program Gastroenterology Board Review, 10/01/2014
Endoscopic Management of Bile Ducts in Liver Transplant Patients, XLIII National Congress, Asociación Mexicana de Endoscopía Gastrointestinal, Mazatlan Sinaloa, Mexico, 09/22/2015
Keynote Lecture: Endoscopic Procedures in Patients with Liver Cirrhosis, XLIII National Congress, Asociación Mexicana de Endoscopía Gastrointestinal, Mazatlan Sinaloa, Mexico, 09/22/2015
Keynote Lecutre: Fatty Liver Epidemic, XXI Annual Conference Mexican Association of Clinical Pathology, Toluca, Mexico, 11/28/2015
Biliary Complications of Liver Transplant, XII Curso Avances en Gastroenterología: Manejo Médico-Quirúrgico Clinica Alemana de Santiago, Santiago, Chile, 03/21/2019
Acute Liver Failure, XII Curso Avances en Gastroenterología: Manejo Médico-Quirúrgico Clinica Alemana de Santiago, Santiago, Chile, 03/21/2019
IgG4 Disease, XII Curso Avances en Gastroenterología: Manejo Médico-Quirúrgico Clinica Alemana de Santiago, Santiago, Chile, 03/21/2019
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Mundo F., Durazo F. Spontaneous Rupture of an Intra-Abdominal Neuroblastoma Manifested as an Acute Abdomen. Annals of the American British Cowdray Hospital. September 1980.
2. Durazo F., Valenzuela JE. Effect of a Single and Repeated Doses of Metoclopramide on Mechanisms of Gastroesophageal Reflux. American Journal of Gastroenterology. 1993 Oct;88(10):1657-1662. PMID: 8213706
3. Cosenza C, Durazo F, Stain S, Jabour N, Selby R. Current Management of Recurrent Pyogenic Cholangitis. American Surgeon. 1999 Oct;65(10):939-943. PMID: 10515539
4. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart and Circ Physiol. 2002;238:H1455-1461. PMID: 12234797
5. Ghobrial RM, Saab S, Lassman C, Lu DS, Raman S, Limanond P, Kunder G, Marks K, Amersi F, Anselmo D, Chen P, Farmer D, Han S, Durazo F, Goldstein LI, Busuttil RW. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transplantation. 2002 Oct;8(10):901-909. PMID: 12360431
6. Han S, Martin P, Edelstein M, Saab S, Hu R, Kunder G, Holt C, Durazo F, Goldstein L, Farmer D, Ghobrial R, Busuttil R. Conversion from Intravenous to Intramuscular Hepatitis B Immune Globulin in Combination with Lamivudine is Safe and Cost-Effective in Patients Receiving Long-Term Prophylaxis to Prevent Hepatitis B Recurrence after Liver Transplantation. Liver Transplantation. 2003 Feb;9(2):182-187. PMID: 12548512
7. Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG, Busuttil RW, Lassman C. Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. American Journal of Transplantation. 2003 Mar;3(3):328-333. PMID: 12614290
8. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, Weaver M, Figueroa J, Khan K, Vargas J, Saab S, Han S, Durazo F, Goldstein LI, Holt C, Busuttil RW. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Annals of Surgery. 2003 May;237(5):666-675; discussion 675-676. PMID: 12724633
9. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Cost and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. American Journal of Gastroenterology. 2003 98(4):763-770. PMID: 12738453
10. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrissey M, Goldstein LI, Ghobrial RM, Busuttil RW. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transplantation. 2003 May;9(5):473-476. PMID: 12740789
11. Saab S, Ly David, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S, Farmer D, Ghobrial R, Yersiz, Chen P, Schwegel K, Goldstein L, Tong M, Busuttil R. Hepatocellular Carcinoma Screening in Patients Waiting for Liver Transplantation: A Decision Analytic Model. Liver Transplantation. 2003 Jul;9(7):672-681. PMID: 12827551
12. Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW. Hepatitis C Positive Grafts May Be Used in Orthotopic Liver Transplantation: A Matched Analysis. American Journal of Transplantation. Sep;3(9):1167-1172, 2003. PMID: 12919097
13. Saab S, Chang AJ, Comulada S, Geevarghese S, Anselmo RDM, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial, RM, Busuttil RW. Outcomes of Hepatitis C- and Hepatitis B Core Antibody- Positive Grafts in Orthotopic Liver Transplantation. Liver Transplantation. 2003 Oct;9(10):1053-1061. PMID: 14526400
14. Kanwal F, Chen D, Ting L, Gornbein J, Saab S, Durazo F, Yersiz H, Farmer D, Ghobrial RM, Busuttil RW, Han S. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transplantation. 2003 Dec;9(12):1312-1319. PMID: 14625832
15. Durazo F, Lassman C, Han S, Saab S, Lee N, Kawano M, Saggi B, Gordon S, Farmer D, Yersiz H, Goldstein L, Ghobrial RM, Busuttil RW. Fulminant Liver Failure Due to Usnic Acid for Weight Loss. American Journal of Gastroenterology. 2004 May;99(5):950-952. PMID: 15128366
16. Saab S, Kalmaz D, Gajjar N, Hiatt J, Durazo F, Han S, Farmer D, Ghobrial RM, Yersiz H, Goldstein L, Lassman C, Busuttil RW. Outcomes of Acute Rejection after Interferon Therapy in Liver Transplant Recipients. Liver Transplantation. 2004 Jul;10(7):859-867. PMID: 15237369
17. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transplantation. 2004 Dec;10(12):1478-1486. PMID: 15558585
18. Neff GW, Reddy RK, Durazo F, Meyer D, Marrero R, Kaplowitz N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. Journal of Hepatology. 2004 Dec;41(6):1062-1064. PMID: 15582145
19. Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. MELD fails to measure quality of life in liver transplant candidates. Liver Transplantation. 2005 Feb;11(2):218-223. PMID: 15666392
20. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma as a Bridge to Liver Transplantation. Hepatology. 2005 May;41(5):1130-1137. PMID: 15841454
21. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S, Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Annals of Surgery. 2005 Jun;241(6):905-916; discussion 916-918. PMID: 15912040
22. Saab S, Niho H, Comulada S, Hiatt J, Durazo F, Han S, Farmer D, Holt C, Yersiz H, Goldstein L, Ghobrial RM, Busuttil RW. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver International. 2005 Oct;25(5):940-945. PMID: 16162150
23. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong M, Busuttil R. The MELD score in advanced liver disease: Association with clinical portal hypertension and mortality. Experimental and Clinical Transplantation. 2006 June;(4) 1:395-399. PMID: 16827633
24. Saab S, Shpaner A, Zhao Y, Brito I, Durazo F, Han S, Farmer D, Ghobrial RM, Yersiz H, Goldstein L, Tong M, Busuttil RW. Prevalence and risk factors for Diabetes Mellitus in moderate term survivors of liver transplantation. American Journal of Transplantation 2006 Aug;6(8):1890-1895. PMID: 16889544
25. Cameron AM, Ghobrial RM, Hiatt JR, Carmody JC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han S, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Annals of Surgery. 2006 Oct;244(4):563-571. PMID: 16998365
26. Spiegel B, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan H, Durazo F, Bacon B, Martin P, Younossi Z, Ong SH, Kanwal F. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: The hepatitis B Quality of Life instrument, version 1.0. Hepatology. 2007 Jul;46(1):113-121. PMID: 17596882
27. Saab S, Oh MK, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong MJ, Busuttil RW. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver Transplantation. 2007 Jul;13(7):1032-1038. PMID: 17600345
28. Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong M, Busuttil R. Employment and quality of life in liver transplant recipients. Liver Transplantation. 2007 Sep;13(9):1330-1338. PMID: 17763388
29. Durazo F, Yan E, Tong MJ. Nonalcoholic fatty liver disease: Identification and treatment. Family Practice Recertification. 2007 Sep;29(9):1-9.
30. Durazo F, Blatt LB, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2008 Oct;23(10):1541-1548. PMID: 18422961
31. Tabibian JH, Lassman CR, Margolis DJ, Landaverde C, Busuttil RW, Durazo F. Intraductal oncocytic papillary neoplasm of the liver: Case and review of a rare variant. Annals of Hepatology. 2008 Apr-Jun;7(2):168-173. PMID: 18626437
32. Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Pretransplant variables associated with quality of life in liver transplant recipients. Liver International. 2008 Sep;28(8):1087-1094. PMID: 18662279
33. Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, Bolus R, Kim SJ, Gralnek IM. Prospective validation of the short form liver disease quality of life instrument. Alimentary Pharmacology Therapeutics. 2008 Nov 1;28(9):1088-1101. PMID: 18671776
34. Shim M, Durazo F. Multinodular fatty liver after herpes-zoster vaccine: case report and review of the literature. Annals of Hepatology. 2008 Oct-Dec;7(4):382-385. PMID: 19034241
35. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment with multiple stents for post-liver transplantation nonanastomotic biliary strictures. Gastrointestinal Endoscopy. 2009 Jun;69(7):1236-1243. PMID: 19249040
36. Tong MJ, Hsien C, Song JJ, Kao JH, Sun H, Hsu L, Han S, Durazo F, Saab S, Blatt LM. Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Digestive Diseases and Sciences. 2009 Jun;54(6):1337-1346. PMID: 19242792
37. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clinical Gastroenterology Hepatology. 2009 Jul;7(7):793-799. PMID: 19306949
38. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transplantation. 2009 Nov;15(11):1525-1534. PMID: 19877207
39. Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Annals of Hepatology. 2009 Oct-Dec;8(4):379-383. PMID: 20009140
40. Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ, Hayashi P, Lee WM, Seeff LB. Hepatotoxicity Due to Hydroxycut: A Case Series. American Journal of Gastroenterology. 2010 Jul;105(7):1561-1566. PMID: 20104221
41. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy. Gastrointestinal Endoscopy. 2010 Mar;71(3):505-512. PMID: 20189508
42. Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clinical Gastroenterology Hepatology. 2010 Aug;8(8):709-717. PMID: 20385251
43. Tong MJ, Hsu L, Hsien C, Kao JH, Durazo F, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International. 2010 Apr 7;4(2):516-522. PMID: 20827410
44. Han SH, Durazo FA, Saab S, Tong MJ. A proposed, evidence-based approach to the treatment of chronic hepatitis B. J Clin Gastroenterol. 2011 Mar;45(3):259-266. PMID: 20856136
45. Tabibian J, Lazo M, Durazo F, Yeh HC, Clark J. Non-alcoholic fatty liver disease across ethno-racial groups: Do Asian-Americans adults represent a new at-risk population? Journal of Gastroenterology Hepatology. 2011 Mar;26(3):501-509. PMID: 21332546
46. Saab S, Desai S, Tsaoi D, Durazo F, Han S, McClune A, Holt C, Farmer D, Goldstein L, Busuttil RW. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. American Journal of Transplantation. 2011 Mar;11(3):511-517. PMID: 21299826
47. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. Journal of American College of Surgeons. 2011 Apr;212(4):514-520; discussion 520-521. PMID: 21463781
48. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, Farmer D, Busuttil RW. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transplantation. 2011 May;17(5):580-590. PMID: 21506246
49. Saab S, Ng V, Landaverde C, Lee SJ, Comulada WS, Arevalo J, Durazo F, Han SH, Younossi Z, Busuttil RW. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transplantation. 2011 May;17(5):567-579. PMID: 21506245
50. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: A 24-year experience in a single center. Archives of Surgery. 2011 Jun;146(6):683-689. PMID: 21690444
51. Chavalitdhamrong D, Jensen DM, Singh B, Kovacs TO, Han SH, Durazo F, Saab S, Gornbein JA. Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clinical Gastroenterology and Hepatology. 2012 Mar;10(3):254-258. PMID: 22155754
52. Agopian V, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo FA, Saab S, Han SB, Xia V, Hiatt JR, Busuttil RW. The Evolution of Liver Transplantation During Three Decades: Analysis of 5347 Consecutive Liver Transplants at a Single Center. Annals of Surgery. 2013 Sep;258(3):409-421. PMID: 24022434
53. Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo FA, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW. Liver Transplantation in Highest-Acuity Recipients: Identifying Factors to Avoid Futility. Annals of Surgery. 2014 Jun;259(6):1186-1194. PMID: 24263317
54. Lee EW, Saab S, Gomes AS, Busuttil RW, McWilliams J, Durazo F, Han SH, Goldstein L, Tafti BA, Moriarty J, Loh CT, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. Clin Transl Gastroenterol. 2014 Oct 2;5: e61. PMID: 25273155
55. Saab S, Manne V, Bau S, Reynolds JA, Allen R, Goldstein L, Durazo F, El Kabany M, Han S, Busuttil RW. Boceprevir in liver transplant recipients. Liver Int. 2015 Jan;35(1):192-197. PMID: 24673728
56. Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS. Intraductal Cooling via a Nasobiliary Tube during Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries. Am J Roentgenol. 2015 June;204(6):1329-1335. PMID: 26001245
57. Park JK, Saab S, Kee ST, Busuttil RW, Kim HJ, Durazo F, Cho SK, Lee EW. Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci. 2015 Jun;60(6):1543-1553. PMID: 25519690
58. Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW. Treating Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin: A Matched Analysis. Clin Transplant. 2015 Sep;29(9):813-819. PMID: 26147216
59. Saab S, Greenberg A, Li E, Bau SN, Durazo F, El Kabany M, Han S, Busuttil RW. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. Liver Int. 2015 Nov;35(11):2442-2447. PMID: 25913321
60. Lu N, Crespi C, Liu N, Vu J, Ahmadieh Y, Wu S, Lin S, McClune A, Durazo FA, Saab S, Han SB, Neiman D, Beaven S, French S. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Research. 2016 Jan:30(1):160-168. PMID: 26621580
61. Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW. Curing Hepatitis C in Liver Transplant Recipients is Associated with Changes in Immunosuppressant use. J Clin Transl Hep. 2016 Mar 28;4(1):32-38 PMID: 27047770
62. Flores YN, Auslander A, Crespi CM, Rodriguez M, Zhang ZF, Durazo F, Salmerón J. Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. J Dig Dis. 2016 May;17(5):304-312. PMID: 26991251
63. Kuei A, Lee EW, Saab S, Busuttil RW, Durazo F, Han SH, ElKabany M, McWilliams JP, Kee ST. Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012. Dig Dis Sci. 2016 Jun 27. PMID: 27349987
64. Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, El-Kabany MM, McWilliams JP, Kee ST. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016 Jul 7;22(25):5780-5789. PMID: 27433091
65. Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ. Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol. 2016 Dec 28;4(4):281-287. PMID: 28097095
66. Vidhyarkorn S, Siripongsakun S, Yu J, Sayre J, Agopian VG, Durazo F, Lu DS. Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients. Liver Transpl. 2017 Mar;23(3):324-329. PMID: 27875639
67. Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. J Clin Gastroenterol. 2017 Feb;51(2):167-173. PMID: 27548734
68. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El Kabany MM, Han SB, Saab S. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Gastroenterol. 2017 Mar 28;5(1):43-49. PMID: 28507926
69. Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavirin in Liver Transplant Recipients with Hepatitis C. J Clin Transl Hepatol. 2017 Jun 28;5(2):101-108. PMID: 28660147
70. Saab S, Sikavi C, Jimenez M, Viramontes M, Allen R, Challita Y, Mai M, Esmailzadeh N, Grotts J, Choi G, Durazo F, El-Kabany M, Han SH, Moreno E. Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients. J Clin Transl Hepatol. 2017 Dec 28;5(4):335-342. PMID: 29226100
71. Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, McWilliams JP, DiNorcia J 3rd, Padia SA, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. American Journal of Gastroenterology. 2018 Aug;113(8);1187-1196. PMID: 29899437
72. Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Impact of Sustained Viral Response with Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients. Experimental and Clinical Transplantation. 2018 Aug;16(4):419-424.
73. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. Journal of Clinical Transplant Hepatology. 2018 Sep 28;6(3):247-250. PMID: 30271735
74. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. Journal of Clinical Transplant Hepatology. 2018 Sep 28;6(3):247-250. PMID: 30271735
75. Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sudaram V, Noureddin M, Ayoub WS, Durazo FA, Benhammou JN, Enayati P, Elashoff D, Goodman MT, Pisegna J, Hussain S. Microbiome and bile acid profiles in duodenal aspirates from liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatology Research. 2018 Dec;48(13):1108-1117. PMID: 29923681
76. Phan J, Ng V, Sheinbaum AJ, French SW, Choi G, El Kabany ME, Durazo FA, Saab S, Tong MJ, Busuttil RW, Han SH. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. Journal of Clinical Gastroenterology. 2019 Apr;53(4):309-313. PMID: 29912756
77. Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver Transpl. 2017 Dec;23(12):1519-1530. PMID: 28926171
 
Books, Chapters, and Reviews
1. Durazo F. Abdominal Tuberculosis. Valenzuela JE and Rodes J (eds), Gastroenterología y Hepatología. Mediterráneo Publisher., 410-416, 1996
2. Durazo F. Cholestatic Liver Diseases. Esrailian E (ed), Gut Instincts, A Clinician's Handbook of Digestive and Liver Diseases. SLACK Incorporated, 265-272, 2012.
3. Durazo FA. Endoscopic Therapy for Esophageal Variceal Hemorrhage. Cameron JL and Cameron AM (ed), Current Surgical Therapy, 11th Edition. Elsevier, 359-361, 2013.
4. Durazo FA, Tong MJ. Unusual Indications for Liver Transplantation. Busuttil RW and Klintmalm GB (ed), Transplantation of the Liver, 3rd Edition. Elsevier, 256-267 2015.
5. Durazo FA. Management of Refractory Ascites. Cameron JL and Cameron AM (ed), Current Surgical Therapy, 12th Edition. Elsevier, 412-417 2017.
6. Durazo FA. Acute Liver Failure in Adults & Children. The Dumont-UCLA Transplant Guide, 4th Edition. UCLA Liver Transplantation, 2018.
 
Non-Refereed Journal Publications/Original Papers
1. Durazo F. Evaluation of Mild Abnormalities of Liver enzymes. The Pulse (Newsletter of the Mullikin Medical Center), September 1994.
2. Durazo F. Evaluation of Mild Abnormalities of Liver enzymes. The Pulse (Newsletter of the Mullikin Medical Center), September 1994.
3. Durazo F. Clinical Usefulness of the Carcinoembrionic Antigen. The Pulse (Newsletter of the Mullikin Medical Center), October 1996.
 
Abstracts
1. Durazo F., Valenzuela JE. Effect of Metoclopramide on the Mechanisms of Gastroesophageal Reflux. Abstract submitted to the American Motility Society. Meeting held in Houston, Texas. October 1986.
2. Selby RR, Korula J, Mateo R, Selby B, Durazo F, Wueste D, Ahluwalia A, Moser J, Genyk Y, Jabbour N. Comparison of the pre-transplant costs and medical acuity between adult cadaveric versus live-donor liver transplant recipients. Abstract, AASLD, 2000
3. Kanwal F, Chen D, Saab S, Durazo F, Busuttil R, Han S. Predictors of Post-Liver Transplant Altered Mental Status of Unclear Etiology. Hepatology 2002;36(4): 189A. (AASLD Poster Presentation).
4. Saab S, De la Rosa P, Nieto J, Durazo F, Han S, Roth B. Costs and Clinical Outcomes of Primary Prophylaxis of Variceal Bleeding in Cirrhotics: A Decision Analytic Model. Abstract, AASLD, 2002.
5. Karsan H, Lee C, Dong P, Durazo F, Saab S, Han S. Do Transjugular Intrahepatic Portosystemic Shunts (TIPSS) for Refractory Ascites Really Work? Hepatology 2002; 36(4): 533A.
6. Saab S, Hur, Ibrahim A, Goldstein L, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial R, Framer D, Busuttil R, Lassman C. Discordance between Alanine Aminotransferase and Liver Histology in the Liver Transplant Recipients Treated with Ribavirin Monotherapy for Recurrent Hepatitis C Virus. Hepatology 2002; 36(4):655A.
7. Saab S, Ghobrial R, Ibrahim A, Han S, Chen P, Farmer D, Durazo F, Yersiz H, Goldstein L, Busuttil R. Hepatitis C Positive Grafts May Be Used in Orthotopic Liver Transplantation: A Matched Analysis. Hepatology 2002: 36(4); 657A.
8. Saab S, Ly D, Nieto J, Kanwal F, Durazo F, Han S, Busuttil RW. Hepatocellular Carcinoma Surveillance in Patients Awaiting Liver Transplantation Can Be Cost-Effective. Hepatology 2002; 36(4): 717A.
9. Saab S, Wang VS, Ibrahim AB, Durazo F, Han SH, Farmer DG, Ghobrial RM, Yersiz H, Morrissey M, Goldstein LI, Busuttil RW. MELD Score Can Predict Post-Orthotopic Liver Transplantation One-Year Patient and Graft Survival. Gastroenterology 2003; 124(4 suppl. 1): A694.
10. Saab S, Wang V, Ibrahim A, Durazo F, Han S, Farmer D, Ghobrial M, Yersiz H, Goldstein L, Busuttil RW. MELD Score Can Predict Post-orthotopic Liver Transplantation One-Year Patient and Graft Survival. American Transplant Congress, Washington, DC, June 2003.
11. Ghobrial M, Huang YM, Farmer D, Carmody I, Gornbein J, Steadman R, Saab S, Goldstein L, Yersiz H, Durazo F, Han S, Tang L, Busuttil RW. Post-transplant Hepatitis C Recurrence is Influenced by Non-viral Transplant Related Factors: Ten-Year Analysis in over 300 Patients. American Transplant Congress, Washington, DC, June 2003.
12. Saab S, Chang A, Comulada S, Geevarghese S, Anselmo D, Ghobrial M, Kunder G, Durazo F, Han S, Farmer D, Yersiz H, Goldstein L, Busuttil R. Outcomes of Hepatitis C and Hepatitis B Core Antibody Positive Grafts in Orthotopic Liver Transplantation. American Transplant Congress, Washington, DC, June 2003.
13. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Farmer DG, Ghobrial RM, Holt CD, Yersiz H, Goldstein LI, Lipshutz GS, Tong MJ, Busuttil RW. Predictors of Mortality and Meld Scores Changes While Waiting for Liver Transplantation. American Journal of Transplantation. 2005, Supp 11: 5, 216-217.
14. Saab S, Ibrahim AB, Shpaner Z, Brito I, Fraser K, Marehbian J, Durazo F, Han S, Farmer DG, Ghobrial RM, Holt CD, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. Prevalence and Risk Factors for Diabetes Mellitus in Liver Transplant Recipients. American Journal of Transplantation. 2005, Supp 11: 5, 205
15. Cameron AM, Ghobrial RM, Gordon SA, Farmer DG, Yersiz H, Hiatt JR, Zimmerman MA, Durazo F, Gornbein J, Busuttil RW. Hepatitis C Recurrence following Liver Transplant is influenced by Non-Viral Factors. American Surgical Association, Boston, MA, April 2006.
16. Saab S, Wiese C, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil R. Predictors of employment in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, October 2006.
17. Spiegel B, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan H, Durazo F, Bacon B, Martin P, Younossi Z, Ong SH, Kanwal F. Development and validation of a disease-targeted health-related quality of life (HRQOL) instrument in chronic hepatitis B infection: The HBQOL V1.0. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, October 2006.
18. Durazo F, Tong MJ, Blatt LB, Corey WG, Lin JH, Han S, Saab S, Busuttil RW. A Comparison of Alphafetoprotein, AFP L3% and Des-Gamma Carboxyprothrombin in Patients with Chronic Hepatitis, Cirrhosis and Hepatocellular Carcinoma. Digestive Diseases Week, Washington, DC, May 2007.
19. Saab S, Surti B, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil RW. Pre-transplant variables predict quality of life in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2007
20. Saab S, Surti B, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil RW. Pre-transplant variables predict quality of life in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2007
21. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment with maximal stenting for post-liver transplantation nonanastomotic biliary strictures. Shanghai - Hong Kong International Liver Congress, Hong Kong, June 2008.
22. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil RW, Durazo F. Maximal endoscopic stenting for post-liver transplantation anastomotic biliary strictures. Shanghai - Hong Kong International Liver Congress, Hong Kong, June 2008.
23. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Maximal endoscopic stenting for post-liver transplantation anastomotic biliary strictures. International Liver Transplantation Society Joint Congress, Paris, France, July 2008.
24. Kanwal F, Asch SM, Kramer JR, Edmundowicz SA, Sanyal AJ, El-Serag HB, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo FA, Bacon BR. Measuring Quality of Care in Patients with Cirrhosis: Development of an Explicit Quality Indicator Set. Gastroenterology, 2009, 136(5 Suppl 1): A10-A11
25. Tabibian J, Lazo M, Durazo F, Yeh HC, Clark JM. Nonalcoholic fatty liver disease: Features and differences in an ethno-racially diverse university setting. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2009.
26. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Nakamura Y, Durazo FA, Tong MJ, Hiatt JR, Busuttil RW. Outcomes Analysis Following Surgical Treatments for Cholangiocarcinoma: A 24-Year Experience in a Single Center. Pacific Coast Surgical Association Kapalua, HI, February 2010.
27. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Saab S, Han SH, Lassman C, Markovic D, Hiatt J, Busuttil RW. Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma: Analysis of 25-Year Experience in a Single Center. Southern Surgical Association Annual Meeting, West Palm Beach, FL, December 2010.
28. Ajwichai K, Tan N, Durazo FA, Raman S. Minimizing Bile Duct Injury during Liver Radiofrequency Ablation of Central Liver Masses: Use of Chilled D5W Perfusion Via Endoscopic Nasobiliary Tube. Radiological Society of North America Annual Meeting, Chicago, IL, November 2011.
29. Lee EW, Kee ST, McWilliams JP, Gomes AS, Durazo F, Saab S, Goldstein L, Busuttil RW. Modified-BRTO (Balloon-occluded Retrograde Transvenous Obliteration) for the treatment of portal hypertensive variceal bleeding. Annual Meeting Society of Interventional Radiology, San Diego, CA, March 2014.
30. Choi HW, Kee ST, Saab S, Durazo F, Gomes AS, McWilliams JP, Busuttil RW, Lee, EW. Predictors of early mortality after transjugular intrahepatic portosystemic shunt (TIPS) creation for management of refractory ascites. Annual Meeting Society of Interventional Radiology, San Diego, CA, March 2014.
31. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El Kabany MM, Han SB, Saab S. Decrease of Alpha-Fetoprotein in Patients with Cirrhosis Treated with Direct Acting Agents. Gastroenterology Updates in IBD & Liver Disease, Maui, HI, February 2017.
32. Nguyen K, Weber A, Choi G, Durazo FA, El Kabany MM, Kang S, Saab S, Han SB. Minimal monitoring in treating Hepatitis C with Direct Acting Antivirals. Gastroenterology Updates in IBD & Liver Disease, Maui, HI, February 2017.
33. Nguyen K, Konyn P, Choi G, Durazo FA, Han SB, Ramirez S, Saab S, El Kabany MM. Lower sustained virologic response in patients with hepatocellular carcinoma treated for hepatitis C with direct acting antivirals. Annual Meeting European Association for the Study of the Liver, Amsterdam, The Netherlands, April 2017.
34. Nguyen KT, Konyn P, Darwish T, Choi G, Durazo FA, Han SB, Ramirez S, Saab S, El Kabany M. Lower sustained virologic response in patients with hepatocellular carcinoma treated for hepatitis C treated with direct acting antivirals. Annual Meeting of the American Association for the Study of Liver Diseases, Washington DC, October 2017.
35. Kamal N, Samala NR, Koh C, Fontana RJ, Stolz A, Durazo FA, Hayashi PH, Hoofnagle JH. Asparaginase-Induced Hepatoxicity. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018.
36. Yanny BT, Saab S, Durazo FA, Latt NL, Mikhail M, Mitry A, Sahota AK. Eight-Week Hepatitis C Treatment with New Direct Acting Agents Have a Better Safety Profile While Effective in the Geriatric Population without Liver Cirrhosis and Hepatitis C Virus-RNA <6 Million IU/MI. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018.
37. Yanny BT, Durazo FA, Aziz A, Busuttil RW, Kaldas FM. Largest Series Exploring Implications of Gamma-Glutamyl Transferase Elevation in Post Liver Transplant Recipients, an Analysis of 511 Consecutive Patients. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018.
38. Perumpail RB, Khemichian S, Lakhoo K, Do AL, Choi G, Durazo F, El Kabany M, Saab S, Busuttil RW, Han SB. Tenofovir alafenamide for hepatitis B virus prophylaxis post-liver transplantation is associated with improved renal function: an interim analysis of a multicenter real-world experience. Annual Meeting European Association for the Study of the Liver, Vienna, Austria, April 2019.